These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15371387)

  • 1. Listening to generic Prozac: winners, losers, and sideliners.
    Druss BG; Marcus SC; Olfson M; Pincus HA
    Health Aff (Millwood); 2004; 23(5):210-6. PubMed ID: 15371387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prozac. A bitter pill.
    McLean B
    Fortune; 2001 Aug; 144(3):118-22, 126, 130-2. PubMed ID: 11499050
    [No Abstract]   [Full Text] [Related]  

  • 3. Lilly goes off Prozac.
    Simons J
    Fortune; 2004 Jun; 149(13):179-80, 182, 184. PubMed ID: 15241951
    [No Abstract]   [Full Text] [Related]  

  • 4. State Medicaid programs missed $220 million in uncaptured savings as generic fluoxetine came to market, 2001-05.
    Kelton CM; Chang LV; Kreling DH
    Health Aff (Millwood); 2013 Jul; 32(7):1204-11. PubMed ID: 23836735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P; Birkett DJ; Dudley J; Stevens A
    Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of generic-only drug benefits on seniors' medication use and financial burden.
    Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
    Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms.
    Panattoni LE
    J Health Econ; 2011 Jan; 30(1):126-45. PubMed ID: 21074873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The unlicensed lives of antidepressants in India: generic drugs, unqualified practitioners, and floating prescriptions.
    Ecks S; Basu S
    Transcult Psychiatry; 2009 Mar; 46(1):86-106. PubMed ID: 19293281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness and cost-utility of cognitive therapy, rational emotive behavioral therapy, and fluoxetine (Prozac) in treating depression: a randomized clinical trial.
    Sava FA; Yates BT; Lupu V; Szentagotai A; David D
    J Clin Psychol; 2009 Jan; 65(1):36-52. PubMed ID: 19051275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The career of a celebrity pill. As Prozac's long reign comes to an end, experts are questioning its legacy.
    Szegedy-Maszak M
    US News World Rep; 2001 Aug; 131(5):38-9. PubMed ID: 11499369
    [No Abstract]   [Full Text] [Related]  

  • 11. The generics in transplantation and the rules on their use.
    Masri M
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study: U.S. generic drugs cost less then Canadian drugs.
    Bren L
    FDA Consum; 2004; 38(4):9. PubMed ID: 15346576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL; Cox ER
    Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
    Kong Y
    Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cheap and cheerful.
    Munro R
    Nurs Times; 2000 Jan 20-26; 96(3):16. PubMed ID: 11961788
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacies receiving massive rebates from generic drug-makers.
    Silversides A
    CMAJ; 2006 Aug; 175(4):342. PubMed ID: 16908889
    [No Abstract]   [Full Text] [Related]  

  • 18. How Barr managed to kill Eli Lilly's patent on Prozac.
    Pabst PL
    Tissue Eng; 2001 Dec; 7(6):843-4. PubMed ID: 11749739
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of generic drug entry on cost-effectiveness analysis.
    Shih YC; Han S; Cantor SB
    Med Decis Making; 2005; 25(1):71-80. PubMed ID: 15673583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference pricing of pharmaceuticals.
    Brekke KR; Königbauer I; Straume OR
    J Health Econ; 2007 May; 26(3):613-42. PubMed ID: 17188769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.